Share of S. aureus infections resistant to methicillin in United Arab Emirates

United Arab Emirates: Share of S. aureus infections resistant to methicillin was 39.9% in 2022. ▲ Rising

Latest (2022)
39.9%
Change on year
up 11.9%
World rank
15th
of 45 countries
All-time high
42.5%
in 2020
All-time low
23.7%
in 2018
Years of data
6
2017–2022

Share of S. aureus infections resistant to methicillin in United Arab Emirates, 2017–2022

0102030402017201920222017: 34.1 %2018: 23.7 %2019: 36.2 %2020: 42.5 %2021: 35.6 %2022: 39.9 %

Source: World Health Organization – processed by Our World in Data. Measured in %.

Analysis

The most recent figure for share of s. aureus infections resistant to methicillin in United Arab Emirates is 39.9%, measured in 2022.

Compared with earlier readings it is up 11.9% on the previous year and up 17.0% over ten years.

That places United Arab Emirates 15th out of 45 countries with data for 2022, putting it in the middle of the range.

Share of S. aureus infections resistant to methicillin in United Arab Emirates, year by year

Annual values for Share of S. aureus infections resistant to methicillin in United Arab Emirates, 2017 to 2022.
Year % Change
2017 34.1%
2018 23.7% -30.5%
2019 36.2% +52.9%
2020 42.5% +17.4%
2021 35.6% -16.2%
2022 39.9% +11.9%

Averages by decade

DecadeAverage LowestHighest Years
2010s 31.3% 23.7% 36.2% 3
2020s 39.4% 35.6% 42.5% 3

Countries ranked near United Arab Emirates

  1. 12 Republic of Korea 45.7% compare
  2. 13 Philippines 44.4% compare
  3. 14 Greece 41.1% compare
  4. 16 Indonesia 35.2% compare
  5. 17 Iran, Islamic Republic of 34.7% compare
  6. 18 Japan 33.9% compare

See the full ranking of 45 places →

More reference data data for United Arab Emirates

All data for United Arab Emirates →

Frequently asked questions

What is share of s. aureus infections resistant to methicillin in United Arab Emirates?
Share of s. aureus infections resistant to methicillin in United Arab Emirates was 39.9% in 2022, according to World Health Organization – processed by Our World in Data.
What is the highest share of s. aureus infections resistant to methicillin recorded in United Arab Emirates?
The highest recorded value was 42.5% in 2020.
What is the lowest share of s. aureus infections resistant to methicillin recorded in United Arab Emirates?
The lowest recorded value was 23.7% in 2018.
How does United Arab Emirates rank for share of s. aureus infections resistant to methicillin?
United Arab Emirates ranks 15th out of 45 countries with data for 2022.
Is share of s. aureus infections resistant to methicillin rising or falling in United Arab Emirates?
Over the last ten years it is up 17.0%. The long-run trend across the full record is rising.
Where does this United Arab Emirates data come from?
The figures come from World Health Organization – processed by Our World in Data, published as part of Share of S. aureus infections resistant to methicillin. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of S. aureus infections resistant to methicillin in United Arab Emirates. Statizoid, drawing on World Health Organization – processed by Our World in Data. Retrieved 07 September 2026, from https://reference.statizoid.com/stat/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/united-arab-emirates/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/united-arab-emirates/">Share of S. aureus infections resistant to methicillin in United Arab Emirates</a> — Statizoid

About this data

Indicator
Share of S. aureus infections resistant to methicillin
Unit
%
Source
World Health Organization – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
45 places, 273 data points, 2016–2022
Last refreshed

Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).